Spiroheterocyclic compounds and their uses as therapeutic agents
US7799798B2 · kind B2 · utility
18Cited by
31References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 2006 |
| Grant date | Sep 21, 2010 |
| Priority date | — |
| Expiry date | Sep 17, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to spiroheterocyclic compounds of formula (I)whereink, j, p, Q, R1, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, that are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising the compounds and methods of using the compounds are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.